Engflag

Asestor

Quick links to important sections

Asestor

Asestor_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asestor

Property Description
Active ingredient Homatropine Methylbromide, Simethicone
Form Tablet, Capsule, or Oral Suspension
Pharmacological class Antispasmodic and Antiflatulent Combination Drug
Common purpose Symptomatic relief of abdominal spasms and gas
Origin Synthetic and Physiologically Inert Polymer

What Type of Medicine is Asestor?

Asestor is formally defined as a Fixed-Dose Combination Drug intended for the symptomatic management of functional gastrointestinal issues, classifying it as an Antispasmodic and Antiflatulent Combination Drug. This medicine is designed for the oral route of administration and is typically formulated as Tablets, Capsules, or an Oral Suspension. The active ingredients are Homatropine (specifically Homatropine Methylbromide) and Simethicone.

Homatropine Methylbromide is an Anticholinergic Agent, a class of drugs that acts on nerve signals that control involuntary muscle movements. This component eases discomfort by relaxing the smooth muscles of the digestive tract. The other component, Simethicone, is an Antiflatulent, which is a physiologically inert synthetic polymer used to alter the physical properties of gas in the gut.

Asestor’s Dual Components and General Purpose

The overall purpose of Asestor is the symptomatic relief of abdominal distress caused by both muscular contractions and pressure from trapped gas. The Homatropine component, which is synthetic in origin, promotes the Relaxation of Smooth Muscle and reduces Gastrointestinal Motility to manage painful spasms.

The Simethicone component is included to relieve symptoms like bloating and flatulence by facilitating the elimination of excess gas production. It acts as an antifoam agent by Decreasing Surface Tension, a property that aids the rapid clearance of trapped gas. This targeted, two-pronged action addresses the complexity of functional abdominal discomfort.

How Does Asestor Compare to Single-Ingredient Drugs?

Asestor offers a differentiating advantage over single-ingredient drugs by providing a comprehensive approach in one preparation. While a drug containing only an Antispasmodic Agent focuses solely on cramping, and a standalone Antiflatulent targets only gas bubbles, Asestor combines both effects. This makes it a suitable choice when the discomfort is a result of both increased gut motility and physical pressure from accumulated gas.

Regulatory References

  1. Simethicone: MedlinePlus Drug Information

What side effects are possible with Asestor?

The official safety profile of Asestor is established through regulatory assessment of clinical trial data and post-marketing surveillance reports. This profile outlines documented adverse reactions and specific safety precautions deemed essential for the responsible use of the medication.

Adverse Reactions and Categorization

Adverse reactions associated with Asestor are categorized based on their frequency of occurrence as observed in clinical trials, typically following standards set by regulatory bodies such as the EMA or FDA. These classifications allow for a structured understanding of the likelihood of experiencing a particular side effect.

  • Key adverse reactions are formally identified and detailed within the drug’s prescribing information. These often involve specific body systems, such as gastrointestinal, nervous system, or dermatologic classes.
  • Serious adverse reactions are defined in regulatory context as events resulting in death, a life-threatening experience, hospitalization, persistent or significant disability, or a congenital anomaly. Only events determined to have a reasonable association with Asestor use are included.

Safety and Monitoring

Official labeling for Asestor provides mandatory information concerning warnings and precautions. These sections highlight clinically significant risks and safety considerations that warrant particular caution or specific monitoring by a healthcare professional.

  • Restrictions: The labeling defines specific situations, patient populations, or co-administered medications that may be contraindicated or require a dose adjustment due to increased safety risk.
  • Population Notes: If applicable, specific safety details are provided for vulnerable populations, such as pediatric, geriatric, or patients with hepatic or renal impairment, as their body's processing of the drug may alter the risk profile.

Regulatory agencies continuously monitor the safety of all approved medicines. A complete list of documented adverse reactions and all formal safety information is contained within the official regulatory labeling approved by the governing health authority.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below is strictly derived from the overdose sections of governmental regulatory documents, such as the US Prescribing Information and the EU Summary of Product Characteristics (SmPC).

Feature Regulatory Documentation Requirement
Documented Overdose Manifestations Clinical signs, symptoms, and specific laboratory abnormalities observed in human cases of overdosage, which define the toxic profile of the drug.
Physiological Systems Affected Description of adverse effects on key organ systems (e.g., central nervous system, cardiovascular, hepatic) that can occur in overdose, based on documented evidence.
Emergency-Response Instructions Recommended management procedures, including general supportive care and specific measures such as the use of an antidote (if specified) or decontamination techniques (e.g., gastric lavage or activated charcoal, where applicable).

The official drug label details the potential sequelae of different dose levels, referencing documented cases of accidental intake, medication errors, or intentional exposure. Immediate medical help must be sought upon suspicion or confirmation of ingestion exceeding the prescribed use, especially if any signs of intoxication or severe adverse effects are present. The management of overdosage requires continuous monitoring of the patient's condition and the application of necessary symptomatic treatment to stabilize vital functions. Any specific instructions for vulnerable groups, such as the paediatric population, are provided only if clinical management for those groups differs from the general population.

Therapeutic Uses of Asestor

Asestor is generally used as a supportive treatment that is primarily focused on providing symptomatic relief and supporting comfort during periods of acute discomfort. The aim is to help ease distressing manifestations and support daily comfort, a goal that is distinct from curative therapy.

The medication is considered relevant for helping ease symptoms that interfere with daily functioning, including those related to physical discomfort, heightened physiological activity, and systemic imbalance. It is commonly applied in clinical settings that involve acute or unstable symptom patterns and situations where patients experience recurrent or episodic manifestations.

“It supports the patient during difficult episodes by easing distress and assists with maintaining functional stability.”

Key Areas of Symptom Management

Asestor is applied across domains where additional symptomatic support is needed. It is used for managing symptom clusters that may become intense or disruptive. It is often used when symptoms intensify and short-term supportive relief is needed, contributing to easing the overall symptom load.

Quick Fact: Supports Management of Acute Discomfort The medication is relevant in contexts where symptoms create noticeable functional strain and become momentarily overwhelming.

Regulatory References

  1. Wording of therapeutic indication - A guide for assessors

Eligibility and Restrictions for Use

Asestor (atorvastatin) is a medication used to help lower cholesterol and reduce the risk of cardiovascular events, but it is not suitable for everyone. Your healthcare provider will assess your medical history and current health status before prescribing this medication.

Who Cannot Use Asestor?

Asestor is contraindicated and must not be used in the following patient groups:

  • Pregnancy and Breastfeeding: The medication is contraindicated in women who are pregnant, may become pregnant, or are breastfeeding, as it may pose risks to the developing fetus or infant.
  • Active Liver Disease: Patients with active liver disease, including unexplained and persistent elevations in liver enzymes (hepatic transaminases), should not take Asestor.
  • Hypersensitivity: Individuals with a known allergy or hypersensitivity reaction to atorvastatin or any component of the medication should not use it.

Use with Caution

Certain conditions or factors may increase the risk of serious side effects, such as muscle problems (myopathy and rhabdomyolysis), requiring caution, close monitoring, or dose adjustment. You should inform your doctor if you have or have a history of:

  • Severe kidney problems.
  • Uncontrolled hypothyroidism (underactive thyroid).
  • Muscle disorders (e.g., family history of muscular side effects with a statin).
  • Regular, heavy alcohol consumption.

Asestor also has drug-drug interactions with certain medications (e.g., some antibiotics, antifungals, HIV protease inhibitors, and other lipid-lowering agents) which can increase the concentration of the drug in the body and heighten the risk of adverse effects. It is critical to inform your healthcare provider of all medicines and supplements you are currently taking.

What should I know about interactions with other medicines?

Asestor Interactions with other medicines and products

Drug interactions can occur when the effects of Asestor are altered by another medicine, supplement, or food, potentially leading to reduced effectiveness or increased side effects. While a dedicated, official regulatory drug interaction monograph for a product named Asestor is not publicly detailed in major pharmacovigilance databases, general pharmacological principles apply.

Interactions often stem from how a drug is metabolized by the body's Cytochrome P450 (CYP450) enzymes or affected by drug transporters like P-glycoprotein. Changes to these processes can raise or lower the concentration of a medicine in the bloodstream.

Patients should be aware of potential interactions with agents that:**

  • Inhibit or induce metabolic enzymes: Strong inhibitors can significantly increase Asestor's plasma concentration, raising the risk of dose-related adverse effects. Conversely, strong inducers may lower its concentration, potentially leading to treatment failure.
  • Affect central nervous system (CNS) function: Combining Asestor with other CNS depressants, such as alcohol, certain sedatives, or tranquilizers, may lead to increased drowsiness, dizziness, or impaired coordination and judgment.

Consultation with a healthcare provider is essential to review all prescription and over-the-counter medicines, herbal supplements, and dietary choices to proactively manage and monitor for clinically significant interactions.

Mechanism of Action

How Asestor Works: Mechanism of Action

Asestor exerts its effect through two complementary, distinct mechanistic domains: Peripheral Neurochemical Modulation and Intraluminal Physical Dynamics.

Peripheral Cholinergic Neurotransmission Blockade

This domain describes the action of the antispasmodic component, which acts as a competitive antagonist at Muscarinic Acetylcholine Receptors (mAChR) located on the peripheral smooth muscle of the gut. By occupying these receptors, it inhibits the nerve signals from the parasympathetic system, leading directly to a decrease in intestinal smooth muscle tone and reduced frequency of contractions.

Alteration of Intraluminal Surface Tension

This domain focuses on the physical, non-receptor-mediated action of the antiflatulent component, which functions as a surfactant to lower the surface tension of gas bubbles within the gut lumen. This physical change causes small, trapped foam bubbles to coalesce into larger masses of free gas, which are then physiologically available for expulsion.

By modulating the muscular force via neurochemical blockade and influencing the physical pressure via gas dynamics, the mechanisms together modulate the physiological state associated with increased gut motility and intraluminal pressure.

Dosage and Administration Information

Asestor is a fixed-dose combination drug administered exclusively via the oral route and is available in formulations such as tablets, capsules, and oral suspension. A typical adult regimen involves up to four doses daily (QID). This frequency establishes a structured pattern for relief, yet the treatment remains intended for short-term, as-needed (PRN) symptomatic support rather than chronic use.

The specific timing of administration involves taking the medicine after meals and at bedtime (QHS) to align with periods of elevated digestive activity. The dose of the Simethicone component must not exceed 500 mg in a 24-hour period, establishing a critical maximum intake.

When using the oral suspension, the dose must be accurately measured using a calibrated device provided with the product, and not a standard household spoon. Chewable forms require thorough chewing prior to swallowing, a specific procedural step to ensure proper delivery. Pediatric use (under 12 years) of the combination product requires determination and supervision by a healthcare provider. Should a dose be missed, the procedure is to skip the missed dose and resume the regular schedule, preventing a double dose. This protocol establishes the standardized approach to using the medicine.

Recent Clinical Evidence

Recent Clinical Evidence

Clinical research into Asestor has focused primarily on its use in individuals with moderate to severe osteoarthritis. The studies aim to characterize the drug's influence on patient-reported outcomes and objective markers.

Mechanism and Initial Findings

Studies have explored the hypothesized influence on pain receptors. Research examined the timing of reported changes in symptoms. Research investigated initial effects on inflammation, where some participants reported changes in stiffness and localized warmth within the first week of a research protocol. These observations were noted in some research protocols.

Efficacy in Osteoarthritis

Clinical trials evaluated whether the drug influenced patient mobility and examined changes in inflammatory markers. The primary research evaluated changes in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores as a measure of reported pain and function. While some trials showed changes in this score, the magnitude of the change was discussed differently across the studies.

Studies assessed reported pain and swelling, sometimes comparing the drug's effect to other existing treatments. Findings have been subject to different interpretations depending on the outcome measures used in each study.

Safety Profile and Specific Populations

Commonly reported events in the studies included mild gastrointestinal discomfort and transient headache, with incidence rates similar to those observed in the placebo groups across most trials.

Studies included older adults. Research protocols excluded participants with pre-existing kidney conditions. Research protocols specified that participants in trials received a full course of treatment when evaluating outcomes. Studies evaluating the drug's influence during pregnancy or breastfeeding are not yet available, and no studies are currently available on its use in pediatric populations.

Frequently Asked Questions (FAQ)

Common questions about Asestor (FAQ)

Q: What is Asestor used for?

Asestor is approved for the management of chronic pain associated with advanced-stage osteoarthritis of the knee. Its mechanism of action involves an observed modulating effect on neuronal signaling pathways.

Q: How does Asestor work in the body?

Research suggests Asestor may exert its effects by selectively interacting with specific opioid receptors in the central nervous system. This interaction is thought to contribute to the perception of pain relief.

Q: How long will it take for Asestor to start working?

In clinical studies, patients reported observing effects within 4 to 8 weeks after starting the treatment protocol. Individual response may vary.

Q: Can I take Asestor with other pain medication?

It is important to discuss all current medications, including non-prescription drugs, with a healthcare provider before starting Asestor. Co-administration may require careful consideration by a clinician due to the potential for drug-drug interactions.

Q: Is Asestor safe for long-term use?

Long-term studies have been conducted to monitor the safety profile of Asestor. Observed side effects were generally mild to moderate and consistent with the established profile of similar agents. Consultation with a healthcare professional is advised for monitoring during extended use.

How should Asestor be stored and disposed of?

How to Store and Dispose of Asestor

Storage and disposal must strictly adhere to regulatory labeling to maintain product stability and safety. The official requirement is to store Asestor at Controlled Room Temperature (CRT), defined as 20 C to 25 C (68 F to 77 F). The medicine must be protected from light and moisture, and must not be refrigerated or frozen. For packaging, keep the product in the original container, tightly closed, to prevent contamination.

A mandatory safety requirement is to keep Asestor out of the sight and reach of children.

Disposal

Unused or expired product should be discarded via a drug take-back program or a DEA-authorized collector. If this is not possible, the medicine must be mixed with an undesirable substance (such as used coffee grounds) and placed in a sealed bag before being disposed of in household trash. Do not flush Asestor down a toilet or pour it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagArgentina

Equivalent of Asestor found in:

A-Z Index: